Congruencetx
Founded 2021 · 5 known investors
Congruence Therapeutics is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to identify new medicines. Its work targets areas including rare diseases within the life sciences industry.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
Congruencetx was founded in 2021 by Clarissa Desjardins.
CD

Clarissa DesjardinsFounder
Investors · 5
Competitors · 1
by search overlapCompanies competing with Congruencetx for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · Jul 2026Frequently asked questions
- What does Congruencetx do?
- Congruence Therapeutics is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to identify new medicines. Its work targets areas including rare diseases within the life sciences industry.
- Who founded Congruencetx?
- Congruencetx was founded by Clarissa Desjardins in 2021.
- Who are Congruencetx's investors?
- Congruencetx's investors include OrbiMed, Alexandria, DIMENSION, BDC Thrive Venture Fund for Women, Lumira Ventures.

